Catalyst Wire Dossier Catalyst Wire Dossier

Hib-MenC-TT vaccine (1 formulation)

Haemophilus influenzae type b meningococcal serogroup C tetanus toxoid conjugate vaccine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hib-MenC-TT vaccine (1 formulation), covering 2012-07-23 to 2012-07-23. Get the full timeline:

Most recent: Clinical Trial Update: 3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age [Phase 2]

See pricing